Zhang Yan, Chen Ping, Cai Shan, Li Jinhua, Chen Yan
Division of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.
Research Unit of Respiratory Diseases, Central South University, Changsha 410011, Hunan, China.
Iran J Basic Med Sci. 2020 Dec;23(12):1610-1617. doi: 10.22038/ijbms.2020.44243.10384.
Apoptosis of pulmonary alveolar septal cells is a pathogenesis characteristic of chronic obstructive pulmonary disease (COPD). Endothelial cell specific molecule-1 (ESM-1) plays an important role in apoptosis of cells. Here, we aimed to determine whether ESM-1 can involve in cell apoptosis in emphysematous mice and stable COPD patients. The sample size of patients was small, so two separate models were studied.
At day 0, 11, and 22, murine were injected IP with 0.3 ml of PBS/Cigarette smoke extract, and euthanized at day 28. Lung tissues from 20 stable COPD patients and 12 Controls were evaluated. Serum was obtained from 25 stable COPD patients and 12 healthy Controls. Pulmonary function, pathology, pulmonary apoptosis index (AI), expression of vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF) and ESM-1 in lung tissue, and concentration of ESM-1 in serum were tested.
Protein expression of ESM-1, VEGF and HGF were decreased significantly in emphysematous mice (<0.05), while AI was increased (<0.05). Correlation analysis indicated that association between AI and ESM-1 was negative (<0.01), VEGF and ESM-1 was positive (<0.01), and HGF and ESM-1 was positive (<0.01). In stable COPD patients, we proved that ESM-1, VEGF and HGF were decreased significantly, while AI was increased (<0.05). Correlation between AI and ESM-1 was negative (<0.01), VEGF and ESM-1 was positive (<0.01), and HGF and ESM-1 was positive (<0.01).
ESM-1 expression decreased and AI increased in emphysematous mice and stable COPD patients. Findings suggested that ESM-1 may be involved in anti-apoptotic therapy of COPD.
肺泡间隔细胞凋亡是慢性阻塞性肺疾病(COPD)的发病机制特征。内皮细胞特异性分子-1(ESM-1)在细胞凋亡中起重要作用。在此,我们旨在确定ESM-1是否参与肺气肿小鼠和稳定期COPD患者的细胞凋亡。患者样本量较小,因此研究了两个独立的模型。
在第0天、第11天和第22天,给小鼠腹腔注射0.3 ml PBS/香烟烟雾提取物,并在第28天实施安乐死。对20例稳定期COPD患者和12例对照者的肺组织进行评估。采集25例稳定期COPD患者和12例健康对照者的血清。检测肺功能、病理学、肺凋亡指数(AI)、肺组织中血管内皮生长因子(VEGF)、肝细胞生长因子(HGF)和ESM-1的表达以及血清中ESM-1的浓度。
肺气肿小鼠中ESM-1、VEGF和HGF的蛋白表达显著降低(<0.05),而AI升高(<0.05)。相关性分析表明,AI与ESM-1呈负相关(<0.01),VEGF与ESM-1呈正相关(<0.01),HGF与ESM-1呈正相关(<0.01)。在稳定期COPD患者中,我们证实ESM-1、VEGF和HGF显著降低,而AI升高(<0.05)。AI与ESM-1呈负相关(<0.01),VEGF与ESM-1呈正相关(<0.01),HGF与ESM-1呈正相关(<0.01)。
肺气肿小鼠和稳定期COPD患者中ESM-1表达降低而AI升高。研究结果提示ESM-1可能参与COPD的抗凋亡治疗。